Japan Committee Recommends Lecanemab Approval

Possible Late November Launch?

Japan’s AD population has grown over years. Lecanemab was granted Priority Review in January.
Japan’s AD population has grown over recent years • Source: Shutterstock

More from Japan

More from Focus On Asia